|
NEOG | Neogen Corp |
|
|
NEOG | Neogen Corp |
| In Vitro & In Vivo Diagnostic Substances |
| Book value per $ invested | $ 1.44 |
| Leverage | 37.28% |
| Market Cap | $ 1.5B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -1.0B |
| Margin | -117.62% |
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.